Japanese shares gain tracking US futures; tech and pharma stocks boost

Japanese shares gain tracking US futures; tech and pharma stocks boost

TOKYO: Japanese shares rose on Monday, erasing early losses, led by tech and pharma stocks as US futures rose on hopes that lawmakers would soon pass a massive economic stimulus to revive growth in the world’s largest economy.

The Nikkei share average gained 0.67 per cent at 28.822.29, after declining 0.2 per cent earlier, while the broader Topix inched up 0.29 per cent to 1,862.00.

“US markets moved irregularly last week but investors were relieved this morning after seeing the rise in US futures,” said Masahiro Ichikawa, chief market strategist, Sumitomo Mitsui DS Asset Management.

Asian shares also rose as concerns over rising Covid-19 cases and delays in vaccine supplies were eclipsed by expectations of a $1.9 trillion fiscal stimulus plan to help revive the US economy.

US lawmakers from both parties said they had agreed that getting the Covid-19 vaccine to Americans should be a priority, but some Republicans objected to such a hefty package only a month after Congress passed a $900 billion relief measure.

Tech shares advanced in Japan, with Toshiba surging 16.88 per cent after the Tokyo Stock Exchange approved on Friday the electronics and infrastructure conglomerate’s return to the bourse’s first section.

Electronic components maker Alps Alpine jumped 6.12 per cent, making it the biggest gainer on the Nikkei index, and camera maker Nikon rose 5.17 per cent.

Drugmakers rose on renewed hopes of Covid-19 vaccine roll-outs. Takeda Pharmaceutical added 3.54 per cent after Japan’s biggest drugmaker last week announced the start of a study of Moderna Inc’s coronavirus vaccine in the country.

Eisai rose 2.8 per cent and Astellas Pharma gained 2.1 per cent.

Sumitomo Corp rose 1.55 per cent as local media reported the trading house would stop investing in new oil development projects as it shifts away from fossil fuels businesses.

Source link


Please enter your comment!
Please enter your name here